The DPP-4 Inhibitor Linagliptin Counteracts Stroke in the Normal and Diabetic Mouse Brain: A Comparison With Glimepiride

Type 2 diabetes is a strong risk factor for stroke. Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor in clinical use against type 2 diabetes. The aim of this study was to determine the potential antistroke efficacy of linagliptin in type 2 diabetic mice. To understand whether efficacy was m...

Descripción completa

Detalles Bibliográficos
Autores principales: Darsalia, Vladimer, Ortsäter, Henrik, Olverling, Anna, Darlöf, Emilia, Wolbert, Petra, Nyström, Thomas, Klein, Thomas, Sjöholm, Åke, Patrone, Cesare
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609599/
https://www.ncbi.nlm.nih.gov/pubmed/23209191
http://dx.doi.org/10.2337/db12-0988

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3609599/
https://www.ncbi.nlm.nih.gov/pubmed/23209191
http://dx.doi.org/10.2337/db12-0988

Ejemplares similares